Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-24 @ 10:29 PM
Study NCT ID:
NCT00304460
Status:
COMPLETED
Last Update Posted:
2019-12-12
First Post:
2006-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Sponsor:
Organization: